Peer-reviewedCC BY-NC-NDTranslational pediatrics
Predictors of using biologics within one year after EEN therapy in pediatric Crohn’s disease
Related
- Greater and Clinically Meaningful Improvement in Health-Related Quality of Life After Device-Aided Therapy in Younger Patients Earlier Within Advanced Parkinson’s Disease: Real-World Evidence from the DATs-PD GETM Spanish Registry
- Dose‐Dependent Efficacy of Radioiodine Therapy in Pediatric Graves’ Disease: A Retrospective Study of Hypothyroidism Risk and the Predictive Role of Thyroid Hormone Parameters
- Complications and predictors of catheter failure in pediatric long peripheral and midline catheters: a prospective observational study
- Remission in moderate-to-severe pediatric asthma: Definitions, assessment, prevalence, predictors, and outcomes—a scoping review
- Contrast-enhanced voiding urosonography - urodynamics in patients with neurogenic bladder dysfunction: a pilot study within pediatric urological practice
BibTeX
@article{anon2026predictors,
title = {{Predictors of using biologics within one year after EEN therapy in pediatric Crohn’s disease}},
journal = {Translational pediatrics},
year = {2026},
month = aug,
url = {https://europepmc.org/article/PMC/PMC13655871},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Predictors of using biologics within one year after EEN therapy in pediatric Crohn’s disease
PY - 2026
DA - 2026/08/17
JO - Translational pediatrics
UR - https://europepmc.org/article/PMC/PMC13655871
SN - 2224-4336
SN - 2224-4344
ER -